Contact this trialFirst, we need to learn more about you.
Vortioxetine for Schizophrenia
Recruiting2 awardsPhase 4
Grand Rapids, Michigan
This trial will compare the effects of the drug vortioxetine to placebo in 88 patients with schizophrenia. The trial will last 16 weeks, and patients will be stratified by illness duration.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.